S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
NASDAQ:AIKI

AIkido Pharma Institutional Ownership

$0.70
+0.01 (+1.71%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.68
$0.71
50-Day Range
$0.67
$0.88
52-Week Range
$0.55
$2.55
Volume
2.19 million shs
Average Volume
7.42 million shs
Market Capitalization
$62.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.42

Institutional Ownership Changes (13F Filings) for AIkido Pharma (NASDAQ:AIKI)

Current
Institutional Ownership
Percentage
10.34%

Number of
Institutional Buyers
(last 12 months)
12

Total
Institutional Inflows
(last 12 months)
$11.26 M

Number of
Institutional Sellers
(last 12 months)
4

Total
Institutional Outflows
(last 12 months)
$1.54 M

Skip Chart & View Institutional Buying and Selling Data

Institutional Buying and Selling by Quarter


AIkido Pharma (NASDAQ AIKI) Institutional Buying and Selling

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2021Millennium Management LLC449,097$0.37M0.0%-47.4%0.501%
11/15/2021GSA Capital Partners LLP151,591$0.13M0.0%-50.6%0.169%
11/12/2021Geode Capital Management LLC732,780$0.60M0.0%+5.3%0.817%
11/10/2021Goldman Sachs Group Inc.63,659$52K0.0%-70.6%0.071%
10/26/2021Game Plan Financial Advisors LLC40,000$33K0.0%N/A0.045%
8/17/2021Millennium Management LLC853,211$0.82M0.0%N/A0.951%
8/16/2021State Street Corp317,314$0.30M0.0%N/A0.354%
8/16/2021Goldman Sachs Group Inc.216,203$0.21M0.0%N/A0.241%
8/13/2021Renaissance Technologies LLC913,373$0.87M0.0%N/A1.020%
8/13/2021Geode Capital Management LLC696,056$0.67M0.0%+13.1%0.777%
8/13/2021Vanguard Group Inc.4,136,875$3.96M0.0%-4.5%4.621%
8/5/2021GSA Capital Partners LLP306,931$0.29M0.0%N/A0.343%
5/19/2021Virtu Financial LLC195,885$0.22M0.0%+121.8%0.219%
5/18/2021Citadel Advisors LLC346,382$0.40M0.0%+310.2%0.387%
5/13/2021Bank of New York Mellon Corp44,191$50K0.0%N/A0.049%
5/12/2021Northern Trust Corp150,654$0.17M0.0%+417.6%0.169%
5/12/2021Geode Capital Management LLC615,177$0.70M0.0%+345.0%0.692%
5/7/2021BlackRock Inc.1,542,219$1.76M0.0%+2,753,862.5%1.735%
2/24/2021Virtu Financial LLC88,326$77K0.0%N/A0.253%
8/14/2020Sabby Management LLC342,121$0.28M0.1%N/A0.980%
8/7/2020Virtu Financial LLC84,325$69K0.0%N/A0.241%
7/31/2020UBS Group AG101,063$83K0.0%N/A0.289%
8/14/2019Citadel Advisors LLC13,870$35K0.0%-62.3%0.589%
8/14/2019Vanguard Group Inc.20,739$52K0.0%-76.5%0.881%
2/9/2018Virtu Financial LLC79,986$0.11M0.0%+190.8%1.284%
8/11/2017Virtu KCG Holdings LLC41,591$0.11M0.0%+78.0%0.841%
1/13/2016Creative Planning0$00.0%-100.0%0.000%
(Data available from 1/1/2016 forward)













AIkido Pharma (NASDAQ:AIKI) Institutional Ownership Frequently Asked Questions

Who are the institutional owners of AIkido Pharma?

During the previous two years, 15 institutional investors and hedge funds held shares of AIkido Pharma. The most heavily invested institutionals were Vanguard Group Inc. ($3.96M), BlackRock Inc. ($1.76M), Renaissance Technologies LLC ($0.87M), Geode Capital Management LLC ($0.60M), Citadel Advisors LLC ($0.40M), Millennium Management LLC ($0.37M), and State Street Corp ($0.30M).Learn more on AIKI's institutional investors

What percentage of AIkido Pharma stock is owned by institutional investors?

10.34% of AIkido Pharma stock is owned by institutional investors. Learn more on AIKI's institutional investor holdings

Which institutional investors have been buying AIkido Pharma stock?

Of the 14 institutional investors that purchased AIkido Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($1.54M), Renaissance Technologies LLC ($0.91M), Millennium Management LLC ($0.85M), Geode Capital Management LLC ($0.59M), Sabby Management LLC ($0.34M), State Street Corp ($0.32M), and GSA Capital Partners LLP ($0.31M).

How much institutional buying is happening at AIkido Pharma?

Institutional investors have bought a total of 5,934,799 shares in the last 24 months. This purchase volume represents approximately $12.13M in transactions.

Which AIkido Pharma institutionals have been selling company stock?

The following institutional investors have sold AIkido Pharma stock in the last 24 months: Millennium Management LLC ($0.40M), Vanguard Group Inc. ($0.19M), GSA Capital Partners LLP ($0.16M), and Goldman Sachs Group Inc. ($0.15M).

How much institutional selling is happening at AIkido Pharma?

Institutional investors have sold a total of 905,027 shares in the last 24 months. This volume of shares sold represents approximately $1.54M in transactions.

This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.